This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Randomized prospective phase II study of temsiroli...
Clinical trial

Randomized prospective phase II study of temsirolimus with or without low-dose interferon alpha in metastatic non-clear renal cell carcinoma: GOIRC study 02/2008

Read time: 1 mins
Last updated:10th Jul 2008
The main objective of this trial is to assess Overall Response Rate (RECIST Criteria); Time to Progression (TTP); Safety; Overall Survival (OS).
Category Value
Study start date 2008-07-10

View full details